How to identify patients with RA-ILD who can benefit from OFEV
01/08/2023 | Author: Boehringer Ingelheim
Document ID: PC-CRP-103942
About Pulmonary Fibrosis
RELATED CONTENT
![A1-R101||A2-R101||RA-ILD DELPHI CONSENSUS SCREENING ALGORITHM](/sg/sites/default/files/styles/bi_gds_card_style/public/2023-12/PC-SG-102040.png)
A1-R101||A2-R101||RA-ILD DELPHI CONSENSUS SCREENING ALGORITHM
![FSIN||How to recognize ILD in PPF patients with CTD](/sg/sites/default/files/styles/bi_gds_card_style/public/2023-12/PC-SG-101955.png)
FSIN||How to recognize ILD in PPF patients with CTD
![Listen to our experts share their thoughts on what PF-ILD is and the high unmet need surrounding this disease](/sg/sites/default/files/styles/bi_gds_card_style/public/2023-12/PC-SG-100877.png)
2:30